Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Degasperi

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Cold Spring Harbor Molecular Case Studies|October 25, 2019
Dramatic response of metastatic cutaneous angiosarcoma to an immune checkpoint inhibitor in a patient with xeroderma pigmentosum: whole-genome sequencing aids treatment decision in end-stage diseaseSophie Momen, Hiva Fassihi, Helen R Davies, et al.
Annals of Hematology|January 18, 2026
BCOR mutations define a therapeutic vulnerability to DHODH Inhibition in acute myeloid leukemiaFlorian Robert, Cherif Badja, Soraya Boushaki, et al.
Clinical Science (London, England : 1979)|October 13, 2012
Mitochondrial reactive oxygen species enhance AMP-activated protein kinase activation in the endothelium of patients with coronary artery disease and diabetesRuth M Mackenzie, Ian P Salt, William H Miller, et al.
Cell|April 16, 2019
A Compendium of Mutational Signatures of Environmental AgentsJill E Kucab, Xueqing Zou, Sandro Morganella, et al.
Breast Cancer Research : BCR|June 14, 2023
Non-BRCA1/BRCA2 high-risk familial breast cancers are not associated with a high prevalence of BRCAnessLars V B Andersen, Martin J Larsen, Helen Davies, et al.
Nature Communications|July 7, 2019
A practical guide for mutational signature analysis in hematological malignanciesFrancesco Maura, Andrea Degasperi, Ferran Nadeu, et al.
Nature Communications|July 27, 2019
Author Correction: A practical guide for mutational signature analysis in hematological malignanciesFrancesco Maura, Andrea Degasperi, Ferran Nadeu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2026
HRDetect in Tubo-ovarian Carcinoma: Stratification and Therapeutic ImplicationsKalyan Banda, Helen R Davies, Yogesh Kumar, et al.
Nature Cancer|February 5, 2022
Author Correction: A practical framework and online tool for mutational signature analyses show intertissue variation and driver dependenciesAndrea Degasperi, Tauanne Dias Amarante, Jan Czarnecki, et al.
Nature Cancer|March 3, 2020
A practical framework and online tool for mutational signature analyses show inter-tissue variation and driver dependenciesAndrea Degasperi, Tauanne Dias Amarante, Jan Czarnecki, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Cold Spring Harbor Molecular Case Studies|October 25, 2019
Dramatic response of metastatic cutaneous angiosarcoma to an immune checkpoint inhibitor in a patient with xeroderma pigmentosum: whole-genome sequencing aids treatment decision in end-stage diseaseSophie Momen, Hiva Fassihi, Helen R Davies, et al.
Annals of Hematology|January 18, 2026
BCOR mutations define a therapeutic vulnerability to DHODH Inhibition in acute myeloid leukemiaFlorian Robert, Cherif Badja, Soraya Boushaki, et al.
Clinical Science (London, England : 1979)|October 13, 2012
Mitochondrial reactive oxygen species enhance AMP-activated protein kinase activation in the endothelium of patients with coronary artery disease and diabetesRuth M Mackenzie, Ian P Salt, William H Miller, et al.
Cell|April 16, 2019
A Compendium of Mutational Signatures of Environmental AgentsJill E Kucab, Xueqing Zou, Sandro Morganella, et al.
Breast Cancer Research : BCR|June 14, 2023
Non-BRCA1/BRCA2 high-risk familial breast cancers are not associated with a high prevalence of BRCAnessLars V B Andersen, Martin J Larsen, Helen Davies, et al.
Nature Communications|July 7, 2019
A practical guide for mutational signature analysis in hematological malignanciesFrancesco Maura, Andrea Degasperi, Ferran Nadeu, et al.
Nature Communications|July 27, 2019
Author Correction: A practical guide for mutational signature analysis in hematological malignanciesFrancesco Maura, Andrea Degasperi, Ferran Nadeu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2026
HRDetect in Tubo-ovarian Carcinoma: Stratification and Therapeutic ImplicationsKalyan Banda, Helen R Davies, Yogesh Kumar, et al.
Nature Cancer|February 5, 2022
Author Correction: A practical framework and online tool for mutational signature analyses show intertissue variation and driver dependenciesAndrea Degasperi, Tauanne Dias Amarante, Jan Czarnecki, et al.
Nature Cancer|March 3, 2020
A practical framework and online tool for mutational signature analyses show inter-tissue variation and driver dependenciesAndrea Degasperi, Tauanne Dias Amarante, Jan Czarnecki, et al.
Pageof 4